NCT04143841 (OMNS) is a NA clinical trial of Viveye OMNS treatment in Dry Eye Syndromes, sponsored by Epitech Mag Ltd..

Who is sponsoring NCT04143841?

NCT04143841 is sponsored by Epitech Mag Ltd..

What drugs are being tested in NCT04143841?

Interventions in NCT04143841: Viveye OMNS treatment, Viveye OMNS sham treatment.

What condition does NCT04143841 study?

NCT04143841 studies Dry Eye Syndromes, ATD, Sjogren's Syndrome.

Is NCT04143841 still recruiting?

NCT04143841 is currently terminated. Last updated 21 April 2021.

Last reviewed 2021-04-21 · How we verify

NCT04143841: OMNS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease

Terminated NA Last updated 21 April 2021

What this trial tests

NA trial testing Viveye OMNS treatment in Dry Eye Syndromes in 50 participants. Terminated before completion.

Timeline

30 October 2019

Primary endpoint
6 January 2021

6 January 2021

Quick facts

Lead sponsor	Epitech Mag Ltd.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	50
Start date	30 October 2019
Primary completion	6 January 2021
Estimated completion	6 January 2021
Sites	3 locations across Israel

Drugs / interventions tested

Viveye OMNS treatment
Viveye OMNS sham treatment

Conditions studied

Dry Eye Syndromes — all drugs for Dry Eye Syndromes →
ATD — all drugs for ATD →
Sjogren's Syndrome — all drugs for Sjogren's Syndrome →

Sponsor

Epitech Mag Ltd.

Who can join

Adults 18 to 80, any sex, with Dry Eye Syndromes or ATD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the safety and effectiveness of Viveye OMNS non-invasive treatment for management of the signs and symptoms of severe dry eye disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dry Eye Syndromes

Currently open trials in the same condition.

NCT07412860 — Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hy · NA · recruiting
NCT06913504 — Comparison Of Blue Light Filter Feature and Blue Blocking Lenses in Digital Device Users With Dry Eye Patients · NA · active not recruiting
NCT06913465 — The Impact of Hypothyroidism on Tear Production and Dry Eye Symptoms: Implications for Optometric Care · active not recruiting
NCT06831253 — Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome · NA · recruiting
NCT06220474 — Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD · NA · recruiting

Other Epitech Mag Ltd. trials

Trials by the same sponsor.

NCT03012698 — Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04143841 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Epitech Mag Ltd.
Last refreshed: 21 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04143841.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing